Stockreport

Seattle Genetics and Astellas Announce Positive Topline Results from Pivotal Trial of Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer

Seagen Inc.  (SGEN) 
Last seagen inc. earnings: 4/30 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.seattlegenetics.com
PDF - Companies Plan to Submit Biologics License Application Later This Year - - Seattle Genetics to Hold Conference Call Today at 9:00 a.m. EDT - [Read more]